Zhifen Chen

930 total citations
20 papers, 448 citations indexed

About

Zhifen Chen is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Zhifen Chen has authored 20 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Epidemiology. Recurrent topics in Zhifen Chen's work include Genetic Associations and Epidemiology (3 papers), Neuroscience and Neural Engineering (3 papers) and Essential Oils and Antimicrobial Activity (3 papers). Zhifen Chen is often cited by papers focused on Genetic Associations and Epidemiology (3 papers), Neuroscience and Neural Engineering (3 papers) and Essential Oils and Antimicrobial Activity (3 papers). Zhifen Chen collaborates with scholars based in China, Germany and United States. Zhifen Chen's co-authors include Heribert Schunkert, Daohang He, Junyang Yi, Lu Zhang, Zhijie Zhang, Zhou Jian, Chad A. Cowan, Haojie Yu, Feng Zhan and Karl‐Ludwig Laugwitz and has published in prestigious journals such as Cell, Nature Genetics and Circulation Research.

In The Last Decade

Zhifen Chen

19 papers receiving 442 citations

Peers

Zhifen Chen

MB

CCM

PS

SURGE

GENET

George S. Katselis Canada

Banappa S. Unger India

Karlheinz Ehrlich Germany

José Ednésio da Cruz Freire Brazil

Yunyun Zhu China

Hanlin Tao United States

Linghang Qu China

Krishnakant G. Soni United States

Xuanming Zhang China

Huang Huang China

George S. Katselis Canada

Zhifen Chen

203 ×1.1

MB

26 ×0.3

CCM

52 ×0.7

PS

44 ×0.7

SURGE

25 ×0.4

GENET

Citations per year, relative to Zhifen Chen Zhifen Chen (= 1×) peers George S. Katselis

Countries citing papers authored by Zhifen Chen

Since Specialization

Citations

This map shows the geographic impact of Zhifen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhifen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhifen Chen more than expected).

Fields of papers citing papers by Zhifen Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhifen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhifen Chen. The network helps show where Zhifen Chen may publish in the future.

Co-authorship network of co-authors of Zhifen Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhifen Chen. A scholar is included among the top collaborators of Zhifen Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhifen Chen. Zhifen Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Xu, Can, Xiaolu Nie, Zhifen Chen, Jason Zhensheng Qu, & Dongjin Wang. (2025). Stenotic left atrioventricular valve after atrioventricular septal defect repair: A distinct surgical phenotype. Journal of Thoracic and Cardiovascular Surgery. 171(3). e66–e67.

2.

Öztürk, Hakime, et al.. (2024). Integration of variant annotations using deep set networks boosts rare variant association testing. Nature Genetics. 56(10). 2271–2280. 3 indexed citations

3.

Su, Shi, Zhifen Chen, Qingen Ke, et al.. (2024). Nanoparticle-Directed Antioxidant Therapy Can Ameliorate Disease Progression in a Novel, Diet-Inducible Model of Coronary Artery Disease. Arteriosclerosis Thrombosis and Vascular Biology. 44(12). 2476–2488. 2 indexed citations

4.

Chen, Zhifen, et al.. (2022). Genome Editing in Dyslipidemia and Atherosclerosis. Advances in experimental medicine and biology. 1396. 139–156. 1 indexed citations

5.

Pang, Shichao, Zhifen Chen, Ulrich Güldener, et al.. (2021). Polygenic risk for coronary artery disease in the Scottish and English population. BMC Cardiovascular Disorders. 21(1). 586–586. 7 indexed citations

6.

Chen, Zhifen & Heribert Schunkert. (2021). Genetics of coronary artery disease in the post‐GWAS era. Journal of Internal Medicine. 290(5). 980–992. 57 indexed citations

7.

Guo, Jia, Xiao Yu Tian, Sandra Ruppenthal, et al.. (2021). Human BIN1 isoforms grow, maintain, and regenerate excitation–contraction couplons in adult rat and human stem cell-derived cardiomyocytes. Cardiovascular Research. 118(6). 1479–1491. 10 indexed citations

8.

Yu, Haojie, Antoine Rimbert, Takafumi Toyohara, et al.. (2019). GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis. Cell. 179(6). 1276–1288.e14. 62 indexed citations

9.

Chen, Zhifen, Haojie Yu, Xu Shi, et al.. (2019). Functional Screening of Candidate Causal Genes for Insulin Resistance in Human Preadipocytes and Adipocytes. Circulation Research. 126(3). 330–346. 49 indexed citations

10.

Goedel, Alexander, et al.. (2018). Subtype-specific Optical Action Potential Recordings in Human Induced Pluripotent Stem Cell-derived Ventricular Cardiomyocytes. Journal of Visualized Experiments. 3 indexed citations

11.

Goedel, Alexander, et al.. (2018). Subtype-specific Optical Action Potential Recordings in Human Induced Pluripotent Stem Cell-derived Ventricular Cardiomyocytes. Journal of Visualized Experiments. 1 indexed citations

12.

Chen, Baili, Jiaming Qian, Kaichun Wu, et al.. (2017). The safety and efficacy of infliximab in patients with active ulcerative colitis in China. 1(1). 20–23. 2 indexed citations

13.

Zhang, Yu, Meng Sun, Lihua Xu, et al.. (2017). Bioinformatics analyses of key genes related with the efficacy of infliximab treatment in patients with inflammatory bowel diseases. Zhonghua shiyan waike zazhi. 34(9). 1576–1579. 1 indexed citations

14.

Chen, Zhifen, Milena Bellin, Tatjana Dorn, et al.. (2016). Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in hiPSC-derived cardiomyocytes. European Heart Journal. 38(4). ehw189–ehw189. 62 indexed citations

15.

Chen, Zhifen, et al.. (2016). Chemical compositions and antibacterial activities of essential oils extracted from Alpinia guilinensis against selected foodborne pathogens. Industrial Crops and Products. 83. 607–613. 47 indexed citations

16.

He, Daohang, et al.. (2016). A potential biopreservative: Chemical composition, antibacterial and hemolytic activities of leaves essential oil from Alpinia guinanensis. Industrial Crops and Products. 94. 281–287. 22 indexed citations

17.

Chen, Zhifen, et al.. (2015). Chemical composition and antibacterial activity of the essential oil from Agathis dammara (Lamb.) Rich fresh leaves. Natural Product Research. 29(21). 2050–2053. 13 indexed citations

18.

Liu, Longhua, Jinyan Xie, Wenwen Guo, et al.. (2014). Evodiamine activates AMPK and promotes adiponectin multimerization in 3T3-L1 adipocytes. Journal of Asian Natural Products Research. 16(11). 1074–1083. 14 indexed citations

19.

Chen, Zhifen, et al.. (2012). Promotion of adiponectin multimerization by emodin: A novel AMPK activator with PPARγ‐agonist activity. Journal of Cellular Biochemistry. 113(11). 3547–3558. 56 indexed citations

20.

Yao, Bixia, Feng Zhan, Zhifen Chen, et al.. (2009). Temperature-induced inversion of elution order in the chromatographic enantioseparation of 1,1′-bi-2-naphthol on an immobilized polysaccharide-based chiral stationary phase. Journal of Chromatography A. 1216(28). 5429–5435. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact